Progressive multiple sclerosis: from pathophysiology to therapeutic strategiesSimon Faissner, V. Wee Yong, Ralf Gold et al.|Nature Reviews Drug Discovery|2019Cited by 456
Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's diseaseMichael R. Jones, Tim Storr, Peter K. Stys et al.|Chemical Science|2017Cited by 93
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010Simon Faissner, Ralf Gold|CNS Drugs|2018Cited by 80
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndromeSimon Faissner, Ralf Gold, Roland Schroers et al.|Proceedings of the National Academy of Sciences|2024Cited by 70
Statin pretreatment is associated with better outcomes in large artery atherosclerotic strokeGeorgios Tsivgoulis, Andrei V. Alexandrov, Aristeidis H. Katsanos et al.|Neurology|2016Cited by 68